Indivior Pharmaceuticals (INDV) Other Gross PP&E Adjustments (2023 - 2025)
Indivior Pharmaceuticals (INDV) has 3 years of Other Gross PP&E Adjustments data on record, last reported at $219.0 million in Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments rose 52.08% year-over-year to $219.0 million; the TTM value through Dec 2025 reached $219.0 million, up 52.08%, while the annual FY2025 figure was $219.0 million, 52.08% up from the prior year.
- Other Gross PP&E Adjustments reached $219.0 million in Q4 2025 per INDV's latest filing, up from $200.0 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $219.0 million in Q4 2025 and bottomed at $119.0 million in Q4 2023.
- Average Other Gross PP&E Adjustments over 3 years is $169.5 million, with a median of $167.5 million recorded in 2025.
- Peak YoY movement for Other Gross PP&E Adjustments: grew 21.01% in 2024, then skyrocketed 52.08% in 2025.
- A 3-year view of Other Gross PP&E Adjustments shows it stood at $119.0 million in 2023, then grew by 21.01% to $144.0 million in 2024, then surged by 52.08% to $219.0 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were $219.0 million in Q4 2025, $200.0 million in Q3 2025, and $175.0 million in Q2 2025.